Surgical Quality Improvement

Neurosurgery Outcomes

January 1, 2021 – December 31, 2021

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall neurosurgery ACS NSQIP performance benchmarked against 357 participating sites.

Neurosurgery (357 Sites)NObservedExpected
30 Day Mortality2722.21%2.21%
30 Day Morbidity27210.66%9.63%
Cardiac 2720.37%0.95%
Unplanned Intubation2721.10%2.04%
Ventilator > 48 Hours2721.47%1.77%
Deep Vein Thrombosis (DVT) / Pulmonary Embolusᵃ2726.25%3.30%
Renal Failure2720.00%0.29%
Urinary Tract Infection (UTI)2720.37%1.76%
Surgical Site Infection (SSI)2722.57%2.26%
C.diff Colitis2720.37%0.15%
Return to Operating Room (ROR)2724.41%5.17%
Readmission 27212.87%10.80%

American College of Surgeons National Surgical Quality Improvement Program, 2022.
ACS NSQIP® Semiannual Report July 12, 2022, Chicago: American College of Surgeons.

ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.